Richard Easton, MD
Orthopaedic Surgery · Rochester Hills, MINPI 1083696355
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.8%), royalties or licence payments and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Pfizer at 44.8% of the total. Reporting peaked in 2019 at $6,496 and has fallen 96.2% since, to $250 in 2025.
Across 30 payments — averaging $307.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$4K
- Cutting Edge Spine, LLC$4K
- Stryker$313
- Globus Medical$254
- Medtronic$85
- Baxter Healthcare$69
- plus $290 from 8 others
Across 48 payments — averaging $32,362 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$1.2M
- Pfizer$315K
- Scilex Pharmaceuticals Inc.$600
What the payments were for
- Royalty or licence$4,08444%
- Speaking & faculty fees$4,14045%
- Food & beverage$1,01111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 2 | $4,140 |
| Cutting Edge Spine, LLC | 2 | $4,084 |
| Stryker | 4 | $313 |
| Globus Medical(2 entities) | 2 | $254 |
| Medtronic(2 entities) | 4 | $85 |
| Baxter Healthcare | 4 | $69 |
| Providence Medical Technology, Inc. | 2 | $57 |
| Si-bone, Inc. | 3 | $54 |
| Spineology Inc. | 1 | $47 |
| Smith+Nephew | 2 | $35 |
| Kuros Biosciences USA, Inc | 1 | $31 |
| Abbott | 1 | $25 |
| Davol Inc. | 1 | $24 |
| Pinnacle, Inc | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVEREST SPINAL SYSTEM$164
- Modulus$164
How this compares
$9,235 in reported general payments places this provider in the 70th percentile of 829 orthopaedic surgery providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 39 | $315 |
| Methylprednisolone | 36 | $237 |
| Gabapentin | 17 | $176 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $153 |
| Oxycodone Hcl | 26 | $115 |
| Methocarbamol | 18 | $114 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $79 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Rochester Hills
- Asheesh BediAnn Arbor$9.4M
- Jerome WiaterBeverly Hills$3.9M
- Mark PintoChelsea$3.2M
- Kyle AndersonBingham Farms$3.1M
- Stephen BartolDetroit$2.6M
- Jad KhalilSouthfield$1.9M
- Jeffrey FischgrundSouthfield$1.8M
- John BlahaAnn Arbor$1.5M
- David MarkelSouthfield$1.5M
- Christopher ChuinardTraverse City$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.